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Text S1. Details on the SPE followed by LC-HRMS screening approach 
Water samples were shipped frozen to Santiago de Compostela, where they were 
subjected to solid-phase extraction (SPE) within 48 h. Eighteen isotopically 
labelled compounds were used as internal standards (IS) for semi-quantification 
purposes (see 2.4.2), amphetamine-d6, benzoylecgonine-d3, cocaine-d3, 
diazepam-d5, fluoxetine-d6, ritalinic acid-d10, sertraline-d3, temazepam-d5 and 
venlafaxine-d6 were supplied by Cerilliant (Round Rock, TX, USA) as 100 μg mL-
1 solutions in MeOH; tri-n-butyl phosphate (TnBP)-d27, tris(2-chloroisopropyl) 
phosphate (TCPP)- d18 and 13C8-perfluorooctane sulfonic acid (13C8-PFOS) 
were supplied by Wellington Laboratories (Guelph, Ontario, Canada); Cyprodinil-
d5 and 13C6 metalaxyl were supplied by Riedel-de Haën (Seelze, Germany); 
Methylparaben-d4 was supplied by CDN Isotopes (Quebec, Canada); Atenolol-
d7 and irbesartan-d4 were supplied by Sigma-Aldrich (St. Louis, MO, USA); 
Metformin-d6 was supplied by TRC Canada (Ontario, Canada).  
Before the SPE process, water samples were vacuum filtered through 0.45 μm 
PVDF filters (Merck Millipore, Darmstadt, Germany). Subsequently, 200 mL 
sample aliquots were spiked with 100 ng of a mixture of the 18 IS and extracted 
by SPE using Oasis HLB 200 mg cartridges (Waters, Milford, MA, USA). Samples 
were percolated through the SPE cartridges, previously conditioned with 5 mL of 
methanol (LC-MS grade, Scharlab, Barcelona, Spain) and 5 mL of ultrapure 
water. Then, the sorbents were washed with 10 mL of ultrapure water and dried 
for ca. 30 min by a nitrogen stream. Analytes were eluted with 10 mL of methanol 
by gravity and the eluates were evaporated to dryness using a Turbo-Vap II 
(Zymark, Hopkinton, MA USA) and a Mini-Vap concentrator (Sigma-Aldrich). 




13 mm 0.2 μm Syringe filter membrane (Pall Corporation, Port Washington, NY, 
USA) and transferred into a glass micro insert prior ultra-high-performance liquid 
chromatography-high resolution mass spectrometric analysis (UHPLC-HRMS). 
Procedural blanks were run with the samples and chemicals detected in the 
blanks were excluded. 
Two μL of sample or procedural blank extracts were injected into an Agilent 
Technologies (Wilmington, DE) 1290 Infinity II LC system. Chromatographic 
separation was carried out with a ZORBAX Extend-C18 1.8 μm (2.1 x 50 mm) 
column supplied by Agilent Technologies and connected to a Supelco 
ColumnSaver 0.5 μm Precolumn Filter (Supelco, Bellefonte, PA). As mobile 
phases, Milli-Q water (0.1% formic acid) (A) and methanol (0.1% formic acid) (B) 
were used at a flow rate of 0.4 mL min-1. The temperature of the column was 
fixed at 35°C. The gradient elution started with 98% A, increasing to 100% B in 
22 min, held for 4 min. Subsequently, it returned to initial conditions (98% A), held 
for 4 min for column back-conditioning.  
A quadrupole-time-of-flight (QTOF) mass spectrometer Agilent 6550 iFunnel Q-
TOF LC/MS system equipped with a Dual Agilent Jet Stream electrospray (ESI) 
ion source was coupled to the UHPLC system. The ESI interface was operated 
in either in positive or negative modes and the voltage of the ESI needle was 
fixed at 3500 V. Nitrogen was used as nebulizing (30 psi) and drying gas (200°C, 
12 L min−1) in the ESI source, and also as collision gas in the MS/MS 
experiments.  
Instrument control and data acquisition were carried out with the MassHunter 
Workstation software B.10.00 from Agilent. Data acquisition was performed using 




DDA) and All Ions pseudo-MS/MS (i.e. data independent acquisition, DIA). In all 
cases, a reference calibration solution, supplied by Agilent, was continuously 
sprayed in the source during the chromatographic run, providing the required 
accuracy of mass assignations.  
The Auto MS/MS method consisted into three consecutive injections per sample 
and polarity operated in the iterative acquisition mode, where those precursors 
that were previously selected for MS/MS fragmentation in previous injections at 
a given retention time are automatically excluded by the software on a rolling 
basis in the following injections. Three collision energies (10, 20 and 40 V) were 
collected for each precursor ion, with a maximum of 2 precursor ions per cycle 
(absolute abundance threshold: 1000 counts). The acquisition frequency in the 
single-MS and the MS/MS were 3 and 6 spectra per second, respectively. During 
each chromatographic run, precursor ions previously selected for fragmentation 
were excluded after 3 spectra (1 per collision energy) and released after 0.5 min. 
The All Ions MS/MS method consisted into 1 injection per sample in each polarity, 
with two alternating collision energies of 0, where little fragmentation is expected, 
and 20 V where fragments are expected, but without selection of precursor ion. 
Hence, in this mode, assignations of potential MS/MS fragments are based on 
the coelution of such potential fragments in the 20 V channel with the precursor 
ion in the 0 V channel. The scanned range was 60-1100 m/z in MS and 30-1000 
m/z in MS/MS modes.  
Data files were processed using the Qualitative Workflows of Agilent MassHunter 
Workstation software B.10.00. Auto MS/MS data files were processed using the 
search algorithm Find by Auto MSMS, which automatically extract the MS and 




for MS/MS acquisition, aligns the spectra, and sorts and display them as a single 
compound. Then, these chemicals are searched against an accurate mass 
MS/MS spectral library of ca. 3200 chemicals, including pharmaceuticals, 
pesticides and other emerging pollutants (full list presented as Table S1). 
Chemicals were considered as tentatively identified when there was a match in 
the MS/MS spectra of at least two product ions with a coherent precursor ion 
(score>80% and mass error lower than 5 ppm). All Ions data files were processed 
using the search algorithm Find by Formula, where the software searches for 
possible ions matching with the empirical formula considering [M+H]+, [M+NH4]+, 
[M+Na]+ ions in positive mode and only [M+H]- in the negative mode (same score 
and ppm thresholds as in  Auto MS/MS). When a match is found, up to 7 product 
ions from the MS/MS library spectrum are extracted as chromatograms from the 
20V channel, generated a unique co-elution score, which indicates confidence of 
the correlation between the precursor and the product ions by abundance, peak 
shape, peak width and retention time. Analytes were deemed identified when 
there were at least 2 of these putative product ions coeluted with the precursor 
ion (coelution score>70%).  
All the analytes detected through the screening process and IS were then 
integrated from the low collision energy MS chromatogram, using the [M+H]+ or 
[M-H]- ion, depending on the source polarity employed using the Mass Hunter 
Quantitative Analysis B 08.00 software. Finally, the intensity of the detected 
substance was presented as area of such compound, divided by the area of the 
IS which ionized in the same polarity mode with the closest retention time, in 




For those chemicals (atenolol, benzoylecgonine, irbesartan, metformin, TCPP, 
TnBP and venlafaxine) detected where the analog isotopically labelled IS was 






Figure S1. Experimental design of the zebrafish bioassay. 24 fertilized eggs were 
selected and transferred to 24-wells plates filled with 2mL of river water samples and 
dechlorinated water for the internal control per plate. Two plates per sample were 






Figure S2 Examples of different abnormalities observed during D.rerio embryonic 
development exposed to river water samples in the present study. A. Normal larve 
D.rerio at 96hpf, lateral view; B. Normal larvae D.rerio at 96hpf  front view. C. Non-
development delay, enlarged yolk-sac and tail deformed; D. Head and tail deformed.  E. 
Tail broken and enlarged yolk-sac. F. Pericardial edema and tail broken; G. Spine 
curvature. H. Yolk-sac and pericardial edema. I. Pericardial edema. J. Scoliosis; K. Short 
larvae; L. Yolk-sac enlarged/malformed, non-development delay. The arrows indicate 





Figure S3. Scatter plots for chemicals (showing the relative response: area/area of 
internal standard in the sample) associated with ecotoxicological endpoints (either 
mortality at 96 hpf or number of anomalies) where a statistically significant p-value 
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